EMA Authorised: Comtess (entacapone) — Orion Corporation

View source ↗

Summary

EMA has authorised Comtess (entacapone) by Orion Corporation for the treatment of Parkinson's disease; entacapone is a COMT inhibitor used as an add-on to levod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Comtess (entacapone)

Snippet

Status: Authorised. Therapeutic area: Parkinson Disease. MAH: Orion Corporation. Decision date: 05/09/2024